NeuroPace (NPCE) Research & Development (2020 - 2026)

NeuroPace's Research & Development history runs 7 years deep, the most recent figure standing at $7.2 million for Q1 2026.

• In Q1 2026, Research & Development fell 3.37% year-over-year to $7.2 million; the TTM figure through Mar 2026 stood at $27.6 million (up 9.2% YoY), while the FY2025 annual figure was $27.9 million, up 17.9% from the prior year.
• Research & Development was $7.2 million for Q1 2026 at NeuroPace, up from $7.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $7.4 million in Q1 2025 to a low of $4.8 million in Q3 2023.
• Historically, Research & Development has averaged $6.0 million across 5 years, with a median of $5.8 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Research & Development surged 36.02% in 2022, then fell 14.54% in 2023.
• A 5-year view of Research & Development shows it stood at $5.1 million in 2022, then gained by 5.66% to $5.4 million in 2023, then increased by 12.52% to $6.0 million in 2024, then gained by 16.15% to $7.0 million in 2025, then increased by 2.31% to $7.2 million in 2026.
• The last three Research & Development figures came in at $7.2 million (Q1 2026), $7.0 million (Q4 2025), and $6.6 million (Q3 2025), per Business Quant data.